Perspective Therapeutics (NYSE:CATX) Earns Outperform Rating from Wedbush
Perspective Therapeutics (NYSE:CATX – Get Free Report)‘s stock had its “outperform” rating reaffirmed by equities researchers at Wedbush in a report issued on Thursday,RTT News reports. They currently have a $11.00 price target on the stock, down from their prior price target of $20.00. Wedbush’s price target suggests a potential upside of 265.45% from the […]
More Stories
New York State Teachers Retirement System Sells 13,673 Shares of ATI Inc. (NYSE:ATI)
New York State Teachers Retirement System trimmed its position in shares of ATI Inc. (NYSE:ATI – Free Report) by 8.7%...
24 Dead, 20 Girls Missing as Flooding Ravages Central Texas
By Tom Ozimek Catastrophic flash flooding triggered by torrential rainfall has left 24 people dead, others missing, and extensive damage...
Stonebridge Financial Group LLC Has $5.81 Million Stake in Alphabet Inc. (NASDAQ:GOOGL)
Stonebridge Financial Group LLC lifted its stake in shares of Alphabet Inc. (NASDAQ:GOOGL – Free Report) by 22.3% during the...
California’s Madre Fire Explodes in Size to Cover 70,800 Acres
By Naveen Athrappully A wildfire in California’s San Luis Obispo County has greatly expanded to now cover almost 70,800 acres...
Skylands Capital LLC Has $28.75 Million Holdings in Alphabet Inc. (NASDAQ:GOOGL)
Skylands Capital LLC boosted its stake in shares of Alphabet Inc. (NASDAQ:GOOGL – Free Report) by 19.6% during the 1st...
Avidian Wealth Enterprises LLC Sells 712 Shares of Alphabet Inc. (NASDAQ:GOOGL)
Avidian Wealth Enterprises LLC reduced its stake in shares of Alphabet Inc. (NASDAQ:GOOGL – Free Report) by 2.4% in the...